Amedica Submits Response to FDA for Clearance of Composite Interbody Spinal Device
Amedica submitted its responses to FDA in relation to the CASCADE clinical trial, and expects a final determination from FDA within 60 days. ...
Amedica submitted its responses to FDA in relation to the CASCADE clinical trial, and expects a final determination from FDA within 60 days. ...
Titan Spine is amending its device warranty to provide a free replacement if any Endoskeleton® interbody fusion devices delaminate or generate...
SI-BONE received FDA 510(k) clearance of a modified indication for the iFuse Implant System®, noting that clinical studies have demonstrated its ability...
As of 2Q15, >15,000 of Spineart’s BAGUERA® C cervical disc replacement devices have been successfully implanted worldwide....
Vertera Spine announced first implantations with the COHERE™ Cervical Interbody Fusion system. Full market launch is expected in coming months....
LDR announced initial implantations of the ROI-C® Titanium-Coated Cervical Cage....
Life Spine announced successful completion of initial cases with the PLATEAU®-Ti Spacer, a titanium interbody system featuring OSSEO-LOC™ surface treatment to support potential...
Eden Spine received CE Mark approval for the SPHYNX™ titanium plate to treat thoracolumbar instability....
Pinnacle Spine launched the InFill® Anterior Lumbar Interbody Fusion device, compatible with the InFill Graft Delivery System....
K2M received FDA 510(k) clearances to market CASCADIA™ Cervical and CASCADIA AN Lordotic Oblique Interbody systems, featuring Lamellar 3D-printed Titanium Technology™....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.